≥99.5% PURITY·HPLC VERIFIED·MASS SPEC CONFIRMED·USA SYNTHESIZED
Tirzepatide
Dual GLP-1 / GIP Receptor Agonist
$119.00
· per vial≥99.5%HPLCRUO
IN STOCK · SHIPS TODAY86 of batch remaining
- Batch
- VR-26-04-TIR-02
- Sealed
- Apr 16, 2026
- Sequence
- Y-Aib-EGTFTSDYSI-Aib-LDKIAQKAFVQWLIAGGPSSGAPPPS (γGlu-C20 fatty acid side chain)
- Molecular Weight
- 4813.5 g/mol
- CAS Number
- 2023788-19-2
- Appearance
- White lyophilized powder
- Storage
- −20°C, protected from light
Research Areas
- · Dual incretin receptor pharmacology
- · Metabolic / glycemic research models
- · Adipose-tissue and weight-regulation studies
Quantity
1
⚠ For research use only. Not for human consumption.
Not approved by the FDA. Not for diagnostic use.
Not approved by the FDA. Not for diagnostic use.
Tirzepatide is a synthetic 39-amino-acid peptide and dual agonist of the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors. The most-studied dual incretin receptor agonist in current literature.